Genetic Insights: Triptan Response in Migraine Treatment

Research Summary

A recent correction to the study titled "Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine-A Systematic Review and Meta-Analysis" in the journal Brain and Behavior highlights key findings about the genetic factors influencing the effectiveness of triptans in migraine treatment. The original research conducted a systematic review and meta-analysis, identifying specific genetic markers that may predict a negative response to triptans, a common migraine therapy. These insights could pave the way for more personalized treatment plans, potentially improving outcomes for migraine sufferers who do not respond well to standard triptan therapies.

Study Details

📄 Title: Correction to "Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine-A Systematic Review and Meta-Analysis".

👥 Research Team: Authors not available

📚 Published In: Brain Behav

📅 Publication Date: 2025 Dec

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.